James Rosinski
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
- Molecular Biology top 10%
- Plant Gene Expression Analysis
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
- Plant biochemistry and biosynthesis
- RNA modifications and cancer
Papers in
- Oncology 4
- Cancer-related Molecular Pathways 2
-
- Glycosylation and Glycoproteins Research 1
- RNA regulation and disease 1
- Co-authors
- William R. AtchleyHolly HiltonKathryn PackmanChristian TovarWeiguo QingXiaolan ZhaoKenneth KolinskyBrian Higgins
- Journals
- Journal of Molecular Evolution (2 papers)The FASEB Journal (2 papers)Molecular Cancer Therapeutics (1 paper)Cellular and Molecular Life Sciences (1 paper)International Journal of Oncology (1 paper)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
James Rosinski
11 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Oncology 483
- Molecular Biology 843
- Biotechnology 87
- Cancer Research 141
- Plant Science 202
Countries citing papers authored by James Rosinski
This map shows the geographic impact of James Rosinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Rosinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Rosinski more than expected).
Fields of papers citing papers by James Rosinski
This network shows the impact of papers produced by James Rosinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Rosinski. The network helps show where James Rosinski may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James Rosinski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 7 | |
| 2 | 2009 | 18 | |
| 3 | 2008 | 1 | |
| 4 | 2007 | 61 | |
| 5 | 2007 | 3 | |
| 6 | Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: Implications for therapy Hit paper breakdown → | 2006 | 553 |
| 7 | Herceptin-refractory ovarian carcinoma cells differentially express genes involved in angiogenesis, invasion, and metastasis | 2005 | 1 |
| 8 | 2003 | 121 | |
| 9 | 2003 | 73 | |
| 10 | 1999 | 51 | |
| 11 | 1998 | 252 | |
| 12 | 1992 | 6 |
About James Rosinski
James Rosinski is a scholar working on Oncology, Molecular Biology, Immunology, Reproductive Medicine and Pharmacology, having authored 12 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (2 papers), Glycosylation and Glycoproteins Research (1 paper), Advanced Breast Cancer Therapies (1 paper), Air Quality and Health Impacts (1 paper), interferon and immune responses (1 paper), Microbial Natural Products and Biosynthesis (1 paper), RNA regulation and disease (1 paper) and Biomarkers in Disease Mechanisms (1 paper). The work is most often cited by research in Oncology (483 citations), Molecular Biology (843 citations), Biotechnology (87 citations), Cancer Research (141 citations) and Plant Science (202 citations). James Rosinski has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include William R. Atchley, Holly Hilton, Kathryn Packman, Christian Tovar, Weiguo Qing, Xiaolan Zhao, Kenneth Kolinsky, Brian Higgins, Lyubomir T. Vassilev and Ola Myklebost. Their work appears in journals such as Journal of Molecular Evolution, The FASEB Journal, Molecular Cancer Therapeutics, Cellular and Molecular Life Sciences and International Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.